Figure 3. Recurrence-Free Survival (RFS) From 3, 6, and 12 Months After Total Neoadjuvant Therapy (TNT).

Probabilities of RFS starting from 3 (A), 6 (B), and 12 (C) months after completion of TNT for patients who underwent surgery and had a pathologic complete response, patients who underwent surgery and had a pathologic incomplete response, and patients who had a clinical complete response and remained in watch-and-wait management.